FIXX · Homology Medicines
Acquired Company
Q32 Bio completed its merger with Homology Medicines on March 25, 2024, with the combined company trading under the ticker QTTB.
The fund invests at least 80% of its net assets (plus borrowings for investment purposes) in the underlying security and financial instruments with economic characteristics that, in combination, provide 200% leveraged exposure to the price of the underlying security, on a daily basis, consistent with the fund’s investment objective. It is non-diversified.
Market Cap
N/A
52 Wk Range
$11.21 - $15.92
Previous Close
$12.57
Open
$11.70
Volume
345
Day Range
$11.70 - $12.36
Enterprise Value
N/A
Cash
N/A
Avg Qtr Burn
N/A
Insider Ownership
N/A
Institutional Own.
N/A
Qtr Updated
N/A